Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Eleven Biotherapeutics Company Profile (NASDAQ:EBIO)

Consensus Ratings for Eleven Biotherapeutics (NASDAQ:EBIO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Eleven Biotherapeutics (NASDAQ:EBIO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/3/2014Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$35.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Citigroup Inc.Initiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/28/2013 forward)